In the Epidemiology of Hearing Loss Study, maintaining high CRP levels over 10 years (two measurements) was even associated with lower risk of cognitive impairment compared with maintaining low levels, whereas a doubling of CRP levels over 20 years was associated with higher risk but only in statin nonusers (37). This evidence concerns the gene CRP and hearing loss disorder.